Amphetamine Related Published Studies
Well-designed clinical trials related to Amphetamine
Preventing growth in amphetamine use: long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. [2009.08.04]
The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial. [2009.07]
Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand. [2009.07]
Amphetamine-induced place preference in humans. [2009.05.15]
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. [2009.04.01]
Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. [2009.04]
A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. [2009.04]
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. [2009.03]
Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02.01]
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. [2009.02]
Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. [2009.01.01]
Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. [2009.01]
Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples. [2009]
Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. [2008.12.04]
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. [2008.12]
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. [2008.12]
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: Results of a randomized, double-blind, placebo-controlled study. [2008.11.04]
Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. [2008.11]
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. [2008.11]
Adolescent methamphetamine use and sexual risk behaviour in secondary school students in Cape Town, South Africa. [2008.11]
Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. [2008.09]
Disulfiram enhances subjective effects of dextroamphetamine in humans. [2008.09]
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. [2008.09]
Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. [2008.09]
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. [2008.07]
Acute physiological and behavioral effects of intranasal methamphetamine in humans. [2008.07]
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. [2008.06]
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. [2008.04]
Bupropion for the treatment of methamphetamine dependence. [2008.04]
The explicit learning of new names for known objects is improved by dexamphetamine. [2008.03]
Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. [2008.03]
Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up. [2008.03]
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. [2008.02]
Riluzole and D-amphetamine interactions in humans. [2008.01.01]
Dexamphetamine enhances explicit new word learning for novel objects. [2007.12]
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. [2007.11.01]
Dexamphetamine boosts naming treatment effects in chronic aphasia. [2007.11]
Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). [2007.08]
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD. [2007.07]
Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine. [2007.07]
Norepinephrine transporter gene variation modulates acute response to D-amphetamine. [2007.06.01]
Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. [2007.06]
Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. [2007.06]
The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. [2007.06]
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. [2007.05.01]
Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. [2007.05]
Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). [2007.04.19]
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity. [2007.04]
Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. [2007.04]
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. [2007.03.30]
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. [2007.03]
Does stress reactivity or response to amphetamine predict smoking progression in young adults? A preliminary study. [2007.02]
Amphetamines for improving recovery after stroke. [2007.01.24]
Contingency management for the treatment of methamphetamine use disorders. [2006.11]
Individual differences in drug abuse vulnerability: d-Amphetamine and sensation-seeking status. [2006.11]
Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. [2006.11]
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. [2006.09]
Serotonin transporter genotype and acute subjective response to amphetamine. [2006.09]
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. [2006.08]
The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. [2006.08]
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. [2006.07]
The effects of caffeine, dextroamphetamine, and modafinil on humor appreciation during sleep deprivation. [2006.06.01]
Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. [2006.05]
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. [2006.05]
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. [2006.04]
Effects of repeated amphetamine administration on antisaccade in schizophrenia spectrum personality. [2006.03.30]
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. [2006.03]
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. [2006.02]
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. [2006.02]
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. [2006.01.04]
Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. [2006.01]
The influence of amphetamine on language activation: an fMRI study. [2006.01]
Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. [2005.12]
Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. [2005.12]
An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. [2005.12]
Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. [2005.12]
Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults. [2005.12]
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. [2005.11.05]
A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis. [2005.11]
Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine. [2005.11]
Safety of intravenous methamphetamine administration during treatment with bupropion. [2005.11]
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. [2005.10]
Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended release in adolescents with ADHD. [2005.10]
Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers. [2005.09.01]
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. [2005.09]
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. [2005.09]
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. [2005.09]
Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation. [2005.08]
A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. [2005.08]
Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. [2005.06]
Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. [2005.06]
Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. [2005.05.09]
When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project. [2005.04]
Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. [2005.03]
Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. [2005.03]
Dopamine transporter gene associated with diminished subjective response to amphetamine. [2005.03]
Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. [2005.03]
Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. [2005.03]
Effects of d-amphetamine in human models of information processing and inhibitory control. [2005.02.14]
|
